Treatment of Atopic Dermatitis with Biologic Drugs
Abstract Atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disease which predominately affects children and usually clears up during infancy or childhood. However, AD may persist with a chronic relapsing course until adulthood or develop at a later age. AD treatment can often be compl...
Saved in:
Main Authors: | Gabriella Fabbrocini (Author), Maddalena Napolitano (Author), Matteo Megna (Author), Nicola Balato (Author), Cataldo Patruno (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024) -
Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
by: Massimiliano Scalvenzi, et al.
Published: (2019) -
Preliminary experience with abrocitinib in severe atopic dermatitis
by: Silvia Ferrucci, et al.
Published: (2024) -
The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data
by: Napolitano M, et al.
Published: (2021) -
A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis
by: Paolo Amerio, et al.
Published: (2024)